𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas

✍ Scribed by Katalin Borka; Péter Kaliszky; Erzsébet Szabó; Gábor Lotz; Péter Kupcsulik; Zsuzsa Schaff; András Kiss

Publisher
Springer
Year
2007
Tongue
English
Weight
469 KB
Volume
450
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreased expression and promoter methyl
Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma
✍ Ilaria Cavallari; Micol Silic-Benussi; Francesca Rende; Annalisa Martines; Paola 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 820 KB

## Abstract Loss of menin, a tumor suppressor coded by the __MEN1__ gene, is a key factor in the pathogenesis of multiple endocrine neoplasia type I and in a percentage of sporadic endocrine tumors of the pancreas and parathyroid glands. This study investigated expression of the menin protein in th

High expression of tumor-associated anti
High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker
✍ Kei Hiraoka; Yasuhiro Hida; Masaki Miyamoto; Taro Oshikiri; Masato Suzuoki; Yosh 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 381 KB

## Abstract RCAS1 (receptor‐binding cancer antigen expressed on SiSo cells) is a recently identified human tumor‐associated antigen expressed on various cancer cells. It is thought that tumor cells evade immune surveillance by expression of RCAS1, which induces apoptotic cell death in receptor‐posi

GADD45α is highly expressed in pancreati
GADD45α is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability
✍ Günter Schneider; Andreas Weber; Ulrich Zechner; Franz Oswald; Helmut M. Friess; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 501 KB

## Abstract Pancreatic ductal adenocarcinoma is one of the most common causes of cancer death in the western civilization. Recently, NF‐κB has been shown to be activated in pancreatic ductal adenocarcinoma through constitutive activation of IκB kinase (IKK). Inhibition of NF‐κB by a super‐inhibitor